Labiotech.eu

In Depth 23 Apr 2025

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in on FDA approval.

April 23, 2025 - 9 minutesmins - By Willow Shah-Neville

Expert Advice 22 Apr 2025

Tariffs and trade war: A guide for expanding biotech business internationally

Find out how you can mitigate the risks on your way to make your biotech company global amidst the tariffs and trade mayhem.

April 22, 2025 - 9 minutesmins - By Jules Adam

Best in Biotech 22 Apr 2025

Seven biotechs to watch in the hepatitis B space

Here we take a look at seven biotechs with clinical drug candidates on a quest to win regulatory approval to treat HBV.

April 22, 2025 - 10 minutesmins - By Roohi Mariam Peter

In Depth 17 Apr 2025

Biomaterials in construction: meet the startups reinventing our buildings

We will explore the various biomaterials making a mark in the construction field and how biotechs could potentially transform a carbon-intensive industry.

April 17, 2025 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 16 Apr 2025

HIV innovation: Six companies developing new treatments in 2025

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

April 16, 2025 - 9 minutesmins - By Jules Adam

News and Trends 16 Apr 2025

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases

Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

April 16, 2025 - 7 minutesmins - By Jules Adam

News and Trends 15 Apr 2025

The AI race in biotech: Is Europe falling behind the US and China?

Find out why Europe has fallen behind the U.S. and China in the AI race in biotech and what it needs to do to catch up.

April 15, 2025 - 9 minutesmins - By Willow Shah-Neville

In Depth 14 Apr 2025

Metabolomics: The study of biology’s dark matter

Learn about metabolomics, biology’s fourth language that has remained vastly untapped up until now and could accelerate biotech research.

April 14, 2025 - 7 minutesmins - By Jules Adam

In Depth 11 Apr 2025

Basel: What’s behind the success of one of Europe’s leading biotech hubs?

Find out what makes Basel’s biotech hub so successful, as it has cemented its place as one of Europe’s brightest life sciences ecosystems.

April 11, 2025 - 7 minutesmins - By Willow Shah-Neville

Podcast 11 Apr 2025

How nanobodies will revolutionize immunotherapy

From llamas and camels to humans worldwide – learn about nanobodies in our talk with Kristian Reich, co-founder of MoonLake Immunotherapeutics.

April 11, 2025

News and Trends 9 Apr 2025

The biotech job market in 2025: Still in survival mode?

The biotech job market has been tough the last few years but is it getting better? Delve into the industry’s job market in 2025.

April 9, 2025 - 7 minutesmins - By Jules Adam

In Depth 9 Apr 2025

Cystic fibrosis: is the next blockbuster a gene therapy?

Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need.

April 9, 2025 - 10 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

Tariffs and trade war: A guide for expanding biotech business internationally

Seven biotechs to watch in the hepatitis B space

Biomaterials in construction: meet the startups reinventing our buildings

HIV innovation: Six companies developing new treatments in 2025

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases

The AI race in biotech: Is Europe falling behind the US and China?

Metabolomics: The study of biology’s dark matter

Basel: What’s behind the success of one of Europe’s leading biotech hubs?

How nanobodies will revolutionize immunotherapy

The biotech job market in 2025: Still in survival mode?

Cystic fibrosis: is the next blockbuster a gene therapy?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!